|
|
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)
Anna Patrikidou
,
Loïc Chaigneau
,
Nicolas Isambert
,
Kyriaki Kitikidou
,
Ryan Shanley
et al.
Journal articles
hal-02872774v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib
Alexis Genthon
,
Franck Emmanuel Nicolini
,
Françoise Huguet
,
Carole Colin-Gil
,
Marc Berger
et al.
Journal articles
hal-02935852v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Une faible charge allélique JAK2V617F pourrait aider à identifier de nouveaux sous-groupes de polyglobulie de Vaquez et de thrombocytémie essentielle
C. Croizier
,
B. Lebecque
,
T. Tassin
,
W. Bombardier
,
A.P. Grandjean
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.115, 2020, Hématologie
Conference poster
hal-02945416v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The Spliceosome: An Another Regulating System of Gene Expression Deregulated in CP-CML CD34+CD15- Cells
B. Lebecque
,
C. Bourgne
,
C. Munje
,
T. Tassin
,
J. Berger
et al.
22nd Annual John Goldman E-Conference on Chronic Myeloid Leukemia: Biology and Therapy, Oct 2020, Mandelieu-La Napoule, France
Conference papers
hal-02945990v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Transition in health care from childhood to adulthood for lysosomal diseases patients in France, current state and priorities: The TENALYS study
Nadia Belmatoug
,
Catherine Marcel
,
Armelle Arnoux
,
Anaïs Brassier
,
Samia Pichard
et al.
Journal articles
hal-03885558v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial
Marc G Berger
Journal articles
hal-03737540v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
À l’aube d’une nouvelle décennie !
Jacques-Olivier Bay
,
Gilles L’allemain
Journal articles
hal-02864008v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rationale for the combination of venetoclax and ibrutinib in Tprolymphocytic leukemia
Christoph Kornauth
,
Charles Herbaux
,
Bernd Boidol
,
Chantal Guillemette
,
Patrick Caron
et al.
Journal articles
hal-03440893v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Etude de phase II de l’association chemofree obinituzumab et idélalisib dans la maladie de Waldenström en rechute ou réfractaire : résultats de l’analyse intermédiaire, après la phase d’induction
C. Tomowiak
,
S. Chevret
,
S. Poulain
,
C. Herbaux
,
A. Perrot
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.135, 2020, Hématologie
Conference poster
hal-02945874v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)
Anne Quinquenel
,
Thérèse Aurran-Schleinitz
,
Aline Clavert
,
Florence Cymbalista
,
Caroline Dartigeas
et al.
Journal articles
hal-03016942v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Liberté, égalité, fraternité à l’épreuve du COVID-19
Jacques-Olivier Bay
,
Gilles L'Allemain
Journal articles
inserm-02565466v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
Thomas Hueso
,
Thomas Gastinne
,
Sylvain Garciaz
,
Emmanuelle Tchernonog
,
Caroline Delette
et al.
Journal articles
hal-02500667v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Semaphorin 7A: A novel marker of disease activity in Gaucher disease
Mélanie Franco
,
Nelly Reihani
,
Lucie Dupuis
,
Emmanuel Collec
,
Thierry Billette de Villemeur
et al.
Journal articles
hal-02872490v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells
Stefania Bottardi
,
Romain Guièze
,
Vincent Bourgoin
,
Nasser Fotouhi-Ardakani
,
Aurore Douge
et al.
Journal articles
hal-02935876v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Double mutation JAK2L611V/V617F dans un cas pédiatrique de polyglobulie
B. Lebecque
,
V. Grèze
,
T. Tassin
,
R. Veyrat-Masson
,
G. Mareynat
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.122, 2020, Hématologie
Conference poster
hal-02945672v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolution du taux de gammaglobulines chez les patients atteints de leucémie lymphoïde chronique traités par ibrutinib
A. Teste
,
C. Protin
,
L. Oberic
,
N. Diop
,
C. Croizier
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.129, 2020, Hématologie
Conference poster
hal-02945852v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple
Jean-Hugues Dalle
,
Etienne Baudoux
,
Sophie Caillat-Zucman
,
Fabienne Colledani
,
Maguy Pereira
et al.
Journal articles
hal-02870571v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France
Françoise Bernaudin
,
Jean-Hugues Dalle
,
Dominique Bories
,
Régis Peffault de Latour
,
Marie Robin
et al.
Journal articles
hal-02377923v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Microbiote intestinal et allogreffe de cellules souches hématopoïétiques
Aurore Douge
,
Jacques-Olivier Bay
,
Aurélie Ravinet
,
Julien Scanzi
Journal articles
hal-02870582v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases
Guillaume Aussedat
,
Alexandra Traverse‐glehen
,
Aspasia Stamatoullas
,
Thierry Molina
,
Violaine Safar
et al.
Journal articles
hal-02872482v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Le Bulletin du Cancer ouvre ses colonnes à l’AERIO
Gilles L’allemain
,
Matthieu Delaye
,
Natacha Naoun
,
Manuel Rodrigues
,
Jacques-Olivier Bay
et al.
Journal articles
hal-02885542v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Management and outcome of primary CNS lymphoma in the modern era
Caroline Houillier
,
Carole Soussain
,
Hervé Ghesquières
,
Pierre Soubeyran
,
Olivier Chinot
et al.
Journal articles
hal-02872770v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P. Pautier
,
N. Penel
,
I. Ray-Coquard
,
A. Italiano
,
E. Bompas
et al.
Journal articles
hal-02429038v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor
Clémence Deteix
,
Florence Mesnil
,
Sabine Furst
,
Noel Milpied
,
Ibrahim Yakoub-Agha
et al.
Journal articles
hal-02872489v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Natural history of untreated patients with type 1 Gaucher disease
C. Serratrice
,
J. Stirnemann
,
A. Berrahal
,
N. Belmatoug
,
F. Camou
et al.
16th Annual WORLDSymposium, Feb 2020, Orlando, United States. 129 (2), pp.S146-S147, 2020, Molecular Genetics and Metabolism
Conference poster
hal-02944814v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The Real-Life Study Evaluating The Efficacy And Safety of Ponatinib « TOPASE » Reveals Induction of Deep Molecular Responses in a Cohort of 75 TKI-Resistant or Intolerant patients with CML
A. Turhan
,
M. Berger
,
Cayssials E.
,
P. Rousselot
,
G. Etienne
et al.
25th Congress of European Hematology Association, Jun 2020, Frankfurt, Germany
Conference poster
hal-02944889v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
L’ajout de la lomustine bénéficie aux leucémies myéloïdes aiguës du sujet âgé avec cytogénétique non-défavorable et d’un profil moléculaire à haut risque de l’European Leukemia Net 2017
L. Largeaud
,
P. Cornillet-Lefebvre
,
J.F. Hamel
,
P.Y. Dumas
,
N. Prade
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.64, 2020, Hématologie
Conference poster
hal-02945560v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Maintien à long terme d’une réponse complète avec maladie résiduelle indétectable après une stratégie de traitement combinant de l’ibrutinib à une immunochimiothérapie ≪ adaptée ≫ chez les patients atteints d’une leucémie lymphoïde chronique non antérieurement traitée
A.S. Michallet
,
M.S. Dilhuydy
,
F. Subtil
,
V. Rouille
,
B. Mahé
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.125, 2020, Hématologie
Conference poster
hal-02945820v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Observatoire de la leucémie myéloïde chronique : un outil unique pour une étude multicentrique dans la « vraie vie » en France
S. Saugues
,
D. Guyotat
,
H. Johnson-Ansah
,
A. Turhan
,
F. Huguet
et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.102, 2020, Hématologie
Conference poster
hal-02945843v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Unexplained Splenomegalies : Interim Data of the French Prospective Multi-Center Splenomegaly Study (SMS)
G. Denis
,
L. Terriou
,
T. Séné
,
R. Costello
,
G. Urbanski
et al.
25th Congress of European Hematology Association, Jun 2020, Frankfurt, Germany
Conference papers
hal-02945930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|